Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

Cancer Research Institute, New York, NY, USA. The cancer cell therapy landscape continues to evolve rapidly. In 2024, the first approvals of tumour-infiltrating lymphocyte (TIL) and T cell receptor ...

Scientists at Duke-NUS Medical School and the National University Health System (NUHS), together with an international team ...

A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...

Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...